Inventor
BONJOUKLIAN ROSANNE
US19 patents
⚠️ This page may combine multiple inventors who share the name “BONJOUKLIAN ROSANNE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LILLY CO ELI
18 patentsUS5504103AApr 2, 1996
Inhibition of phosphatidylinositol 3-kinase with 17 β-hydroxywortmannin and analogs thereof
LILLY CO ELI96 citations94
US4874782AOct 17, 1989
Furanone derivatives
LILLY CO ELI30 citations91
US6670373B1Dec 30, 2003
Compounds and method for inhibiting MRP1
LILLY CO ELI27 citations88
US7582652B2Sep 1, 2009
Kinase inhibitors
LILLY CO ELI19 citations79
US7320995B2Jan 22, 2008
Benzimidazoles and benzothiazoles as inhibitors of map kinase
LILLY CO ELI12 citations77
US4870185ASep 26, 1989
Hapalindoles
LILLY CO ELI6 citations73
US4647685AMar 3, 1987
2-alkoxy-1-((2-trialkylaminoethoxy)phosphinyloxy)-alkenes and alkynes, hydroxy inner salts
LILLY CO ELI11 citations73
US4266049AMay 5, 1981
Process for 3-iodomethyl cephalosporins
LILLY CO ELI13 citations73
US5292647AMar 8, 1994
Strain of streptomyces for producing avermectins and processes therewith
LILLY CO ELI7 citations72
US7365066B2Apr 29, 2008
Pyrazolopyridine derivatives as pharmaceutical agents
LILLY CO ELI8 citations71
US6686376B2Feb 3, 2004
Methods and compounds for inhibiting MRP1
LILLY CO ELI5 citations62
US4675390AJun 23, 1987
2-deoxypentose derivatives
LILLY CO ELI5 citations62
US4612330ASep 16, 1986
Antiinflammatory method
LILLY CO ELI3 citations62
US5110800AMay 5, 1992
Derivatives of erythromycylamine
LILLY CO ELI5 citations60
US6743794B2Jun 1, 2004
Methods and compounds for inhibiting MRP1
LILLY CO ELI7 citations58
US7037921B2May 2, 2006
Compounds and methods for inhibiting MRP1
LILLY CO ELI0 citations51
US4659859AApr 21, 1987
2-alkoxy-1-alkoxy phosphoryl dichlorides
LILLY CO ELI1 citations51
US7863310B2Jan 4, 2011
Kinase inhibitors
LILLY CO ELI0 citations35